Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants

Pediatric Infectious Disease Journal

Volumn 30, Issue 7, 2011, Pages 570-574

  D'Angio, Carl T ^a,f   Heyne, Roy J ^b   Duara, Shahnaz ^c   Holmes, Lucy C ^d   O'Shea, T Michael ^e   Wang, Hongyue ^a   Wang, Dongwen ^a   Sánchez, Pablo J ^b   Welliver, Robert C ^d   Ryan, Rita M ^d   Schnabel, Kenneth C ^a   Hall, Caroline B ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

immunization; influenza vaccines; premature infant; vaccines; very low birth weight infant

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; APNEA; ARTICLE; CHILD; CLINICAL TRIAL; EXTREMELY LOW BIRTH WEIGHT; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SERODIAGNOSIS; TERM BIRTH;

EID: 79959731560     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820c1fdf     Document Type: Article

References (34)

1. Anonymous. A culture of prevention: a model of control for vaccinepreventable diseases, final report. In: XVI Meeting of the Technical Advisory Group (TAG) on Vaccine-Preventable Diseases of the Pan American Health Organization. Mexico City, Mexico: Pan American Health Organization; 2004:27.
2. Poehling KA, Edwards KM, Weinberg GA, et al. The under-recognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
3. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007;195:1126-1136. (Pubitemid 46543443)
4. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353:2559-2567. (Pubitemid 41785893)
5. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004; 113:1758-1764. (Pubitemid 38697988)
6. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239. (Pubitemid 30058954)
7. Stein M, Tasher D, Glikman D, et al. Hospitalization of children with influenza A (H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey. Arch Pediatr Adolesc Med. 2010;164:1015-1022.
8. Louie JK, Gavali S, Acosta M, et al. Children hospitalized with 2009 novel influenza A (H1N1) in California. Arch Pediatr Adolesc Med. 2010;164: 1023-1031.
9. Heron M, Sutton PD, Xu J, et al. Annual summary of vital statistics: 2007. Pediatrics. 2010;125:4-15.
10. Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990;144:595-600. (Pubitemid 20153420)
11. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA. 2000;284:1677-1682.
12. Maeda T, Shintani Y, Nakano K, et al. Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months. Pediatr Int. 2004; 46:122-125. (Pubitemid 38526603)
13. Fujieda M, Maeda A, Kondo K, et al. Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season. Vaccine. 2006;24:957-963. (Pubitemid 43185313)
14. Smith S, Demicheli V, Di Pietrantonj C, et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2006: CD004879.
15. Szilagyi PG, Fairbrother G, Griffin MR, et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med. 2008;162:943-951.
16. Groothuis JR, Levin MJ, Lehr MV, et al. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine. 1992; 10:221-225.
17. Groothuis JR, Lehr MV, Levin MJ. Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. Vaccine. 1994;12:139-141. (Pubitemid 24041931)
18. Sasaki Y, Kusuhara K, Saito M, et al. Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants. Vaccine. 2006;24:2208-2212. (Pubitemid 43255165)
19. Hsiung GD. Hemagglutination and hemagglutination-inhibition test. In: Hsiung GD, Fong CK, Landry ML, eds. Hsiung's Diagnostic Virology: As Illustrated by Light and Electron Microscopy. 4th ed. New Haven, CT: Yale University Press; 1994:69-75.
20. Walter EB, Rajagopal S, Zhu Y, et al. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? Vaccine. 2010;28:4376-4383.
21. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1-62.
22. Potter CW, Jennings R, Nicholson K, et al. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond). 1977;79:321-332.
23. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull. 1979;35:69-75. (Pubitemid 9096975)
24. Mitchell DK, Ruben FL, Gravenstein S. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004. Pediatr Infect Dis J. 2005;24:925-927. (Pubitemid 41475932)
25. Clover RD, Crawford S, Glezen WP, et al. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis. 1991;163:300-304.
26. Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis. 1991;2:140-146.
27. Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis. 2000;182:1218-1221.
28. Neuzil KM, Dupont WD, Wright PF, et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001;20:733-740. (Pubitemid 32758013)
29. Joshi AY, Iyer VN, St Sauver JL, et al. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study. Vaccine. 2009;27:4457-4461.
30. Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365:773-780. (Pubitemid 40311364)
31. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005;116:e397-e407. (Pubitemid 44339432)
32. Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. 2008; 122:911-919.
33. Walter EB, Englund JA, Blatter M, et al. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Pediatr Infect Dis J. 2009;28:1099-1104.
34. Englund JA, Walter E, Black S, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized doubleblind placebo-controlled study. Pediatr Infect Dis J. 2010;29:105-110.